<DOC>
	<DOCNO>NCT00370812</DOCNO>
	<brief_summary>This randomize clinical trial study identify role AMT ( amniotic membrane transplantation ) treat epithelial defect , symblepharon prevention prevent corneal vascularization opacity decrease pain improve visual acuity , patient acute chemical burn .</brief_summary>
	<brief_title>The Role Amniotic Membrane Transplantation Ocular Chemical Burns</brief_title>
	<detailed_description>The study patient grade II-IV acute ocular chemical burn ( Roper - Hall classification ) first 2 week injury . After topical anesthesia , patient initially receive first aid therapy ; include irrigation normal saline normalize ocular surface PH removal early particulate maeuil debris . After complete examination obtain informed consent , patient randomize use treatment assignment list either AMT conventional medical therapy ( group A ) medical treatment ( group B ) . In patient bilateral injury eye randomize separately . AMT perform within 24h presentation . amniotic membrane remain place 7-14 day . The patient examine day 1 , 3 , 7 , 10 , 14 , 21 , 28 biweekly 3 month monthly ( 1 year every visit , visual acuity ( sneillen chart ) , reduction pain ( subjectively ) size corneal epithelial defect ( fluorseein satiny extent corneal vascularization opacity , symblepharon formation assess . Digital photographs visit obtain .</detailed_description>
	<mesh_term>Eye Burns</mesh_term>
	<criteria>Patients chemical eye burn grade 24 Burning occur 2 week Grade I burn More 2 week pass burn Follow patient disconnect 6 month</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>amniotic membrane transplantation</keyword>
	<keyword>ocular chemical burn</keyword>
</DOC>